Annals of Oncology

in this issue:

in this issue
Ann Oncol 18: 209; doi:10.1093/annonc/mdl497
[Extract] [Full Text] [PDF] [Request Permissions]

editorials:

EC de Haas, D. Th. Sleijfer, and JA Gietema

Follow-up of successfully treated testicular cancer patients: consequences of the metabolic syndrome
Annals of Oncology Advance Access published on January 17, 2007
Ann Oncol 18: 211-212; doi:10.1093/annonc/mdl480
[Extract] [Full Text] [PDF] [Request Permissions]

P Zola and A Ferrero

Is carboplatin–paclitaxel combination the standard treatment of elderly ovarian cancer patients?
Annals of Oncology Advance Access published on January 17, 2007
Ann Oncol 18: 213-214; doi:10.1093/annonc/mdl483
[Extract] [Full Text] [PDF] [Request Permissions]

reviews:

S Beslija, J Bonneterre, H Burstein, V Cocquyt, M Gnant, P Goodwin, V Heinemann, J Jassem, WJ Köstler, M Krainer, S Menard, T Petit, L Petruzelka, K Possinger, P Schmid, E Stadtmauer, M Stockler, S Van Belle, C Vogel, N Wilcken, C Wiltschke, CC Zielinski, and H Zwierzina

Second consensus on medical treatment of metastatic breast cancer
Annals of Oncology Advance Access published on July 10, 2006
Ann Oncol 18: 215-225; doi:10.1093/annonc/mdl155
[Abstract] [Full Text] [PDF] [Request Permissions]

G Parmiani, C Castelli, L Pilla, M Santinami, MP Colombo, and L Rivoltini

Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients
Annals of Oncology Advance Access published on November 20, 2006
Ann Oncol 18: 226-232; doi:10.1093/annonc/mdl158
[Abstract] [Full Text] [PDF] [Request Permissions]

SM Grunberg

Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis
Annals of Oncology Advance Access published on November 15, 2006
Ann Oncol 18: 233-240; doi:10.1093/annonc/mdl347
[Abstract] [Full Text] [PDF] [Request Permissions]

original articles:

urogenital tumors:

HS Haugnes, N Aass, SD Fosså, O Dahl, O Klepp, EA Wist, J Svartberg, T Wilsgaard, and RM Bremnes

Components of the metabolic syndrome in long-term survivors of testicular cancer
Annals of Oncology Advance Access published on October 23, 2006
Ann Oncol 18: 241-248; doi:10.1093/annonc/mdl372
[Abstract] [Full Text] [PDF] [Request Permissions]

TK Choueiri, BI Rini, JA Garcia, RC Baz, RM Abou-Jawde, SG Thakkar, P Elson, TM Mekhail, M Zhou, and RM Bukowski

Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma
Annals of Oncology Advance Access published on October 23, 2006
Ann Oncol 18: 249-255; doi:10.1093/annonc/mdl371
[Abstract] [Full Text] [PDF] [Request Permissions]

gynecologic tumors:

O Trédan, J-F Geay, S Touzet, R Delva, B Weber, J Cretin, J Provencal, J Martin, L Stefani, E Pujade-Lauraine, G Freyer, and For the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO)

Carboplatin/cyclophosphamide or carboplatin/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens
Annals of Oncology Advance Access published on November 2, 2006
Ann Oncol 18: 256-262; doi:10.1093/annonc/mdl400
[Abstract] [Full Text] [PDF] [Request Permissions]

J-M Ferrero, B Weber, J-F Geay, D Lepille, H Orfeuvre, M Combe, F Mayer, B Leduc, H Bourgeois, D Paraiso, and E Pujade-Lauraine

Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial
Annals of Oncology Advance Access published on November 15, 2006
Ann Oncol 18: 263-268; doi:10.1093/annonc/mdl376
[Abstract] [Full Text] [PDF] [Request Permissions]

J Kodama, Hasengaowa, T Kusumoto, N Seki, T Matsuo, Y Ojima, K Nakamura, A Hongo, and Y Hiramatsu

Prognostic significance of stromal versican expression in human endometrial cancer
Annals of Oncology Advance Access published on October 25, 2006
Ann Oncol 18: 269-274; doi:10.1093/annonc/mdl370
[Abstract] [Full Text] [PDF] [Request Permissions]

IF van Luijk, C Coens, MEL van der Burg, A Kobierska, M Namer, C Lhomme, P Zola, G Zanetta, JB Vermorken, and For the Gynecological Cancer Group of the European Organization for Research and Treatment of Cancer

Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix
Annals of Oncology Advance Access published on October 23, 2006
Ann Oncol 18: 275-281; doi:10.1093/annonc/mdl384
[Abstract] [Full Text] [PDF] [Request Permissions]

F Hilpert, A du Bois, ER Greimel, J Hedderich, G Krause, L Venhoff, S Loibl, and J Pfisterer

Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged 70 years with advanced ovarian cancer—a study by the AGO OVAR Germany
Annals of Oncology Advance Access published on November 2, 2006
Ann Oncol 18: 282-287; doi:10.1093/annonc/mdl401
[Abstract] [Full Text] [PDF] [Request Permissions]

breast cancer:

G Sanna, K Lorizzo, N Rotmensz, V Bagnardi, S Cinieri, M Colleoni, F Nolè, and A Goldhirsch

Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors
Annals of Oncology Advance Access published on November 6, 2006
Ann Oncol 18: 288-292; doi:10.1093/annonc/mdl399
[Abstract] [Full Text] [PDF] [Request Permissions]

T Younis, D Rayson, R Dewar, and C Skedgel

Modeling for cost-effective-adjuvant aromatase inhibitor strategies for postmenopausal women with breast cancer
Annals of Oncology Advance Access published on November 9, 2006
Ann Oncol 18: 293-298; doi:10.1093/annonc/mdl410
[Abstract] [Full Text] [PDF] Supplementary Material [Request Permissions]

gastrointestinal tumors:

L Rubbia-Brandt, E Giostra, C Brezault, AD Roth, A Andres, V Audard, P Sartoretti, B Dousset, PE Majno, O Soubrane, S Chaussade, G Mentha, and B Terris

Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery
Annals of Oncology Advance Access published on October 23, 2006
Ann Oncol 18: 299-304; doi:10.1093/annonc/mdl386
[Abstract] [Full Text] [PDF] [Request Permissions]

J Souglakos, A Kalykaki, L Vamvakas, N Androulakis, K Kalbakis, S Agelaki, N Vardakis, M Tzardi, AP Kotsakis, J Gioulbasanis, D Tsetis, G Sfakiotaki, D Chatzidaki, D Mavroudis, and V Georgoulias

Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy
Annals of Oncology Advance Access published on November 1, 2006
Ann Oncol 18: 305-310; doi:10.1093/annonc/mdl392
[Abstract] [Full Text] [PDF] [Request Permissions]

Y Liu, Q-Y Zhang, N Qian, and R-L Zhou

Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer
Annals of Oncology Advance Access published on October 30, 2006
Ann Oncol 18: 311-316; doi:10.1093/annonc/mdl394
[Abstract] [Full Text] [PDF] [Request Permissions]

lung cancer:

Y Ohe, Y Ohashi, K Kubota, T Tamura, K Nakagawa, S Negoro, Y Nishiwaki, N Saijo, Y Ariyoshi, M Fukuoka, and For the FACS Cooperative Group

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan
Annals of Oncology Advance Access published on November 1, 2006
Ann Oncol 18: 317-323; doi:10.1093/annonc/mdl377
[Abstract] [Full Text] [PDF] [Request Permissions]

P Comella, G Filippelli, G De Cataldis, B Massidda, G Frasci, L Maiorino, C Putzu, S Mancarella, S Palmeri, R Cioffi, M Roselli, F Buzzi, V Milia, A Gambardella, D Natale, M Bianco, M Ghiani, and P Masullo

Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)
Annals of Oncology Advance Access published on October 27, 2006
Ann Oncol 18: 324-330; doi:10.1093/annonc/mdl396
[Abstract] [Full Text] [PDF] [Request Permissions]

CM Rocha-Lima, JE Herndon, II, ME Lee, JN Atkins, A Mauer, E Vokes, MR Green, and For the Cancer and Leukemia Group B

Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902
Annals of Oncology Advance Access published on October 25, 2006
Ann Oncol 18: 331-337; doi:10.1093/annonc/mdl375
[Abstract] [Full Text] [PDF] [Request Permissions]

BM Fischer, J Mortensen, SW Langer, A Loft, AK Berthelsen, BL Petersen, G Daugaard, U Lassen, and HH Hansen

A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis
Annals of Oncology Advance Access published on October 23, 2006
Ann Oncol 18: 338-345; doi:10.1093/annonc/mdl374
[Abstract] [Full Text] [PDF] [Request Permissions]

hematologic malignancies:

L Arcaini, S Burcheri, A Rossi, M Paulli, R Bruno, F Passamonti, E Brusamolino, A Molteni, A Pulsoni, MC Cox, L Orsucci, A Fabbri, M Frezzato, MT Voso, F Zaja, F Montanari, M Merli, C Pascutto, E Morra, S Cortelazzo, and M Lazzarino

Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT
Annals of Oncology Advance Access published on October 27, 2006
Ann Oncol 18: 346-350; doi:10.1093/annonc/mdl388
[Abstract] [Full Text] [PDF] [Request Permissions]

F Di Raimondo, L Caruso, G Bonanno, P Naso, A Chiarenza, P Fiumara, A Bari, GA Palumbo, A Russo, and R Giustolisi

Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma?
Annals of Oncology Advance Access published on October 25, 2006
Ann Oncol 18: 351-356; doi:10.1093/annonc/mdl378
[Abstract] [Full Text] [PDF] [Request Permissions]

B Klimm, HT Eich, H Haverkamp, A Lohri, P Koch, F Boissevain, G Trenn, P Worst, E Dühmke, RP Müller, K Müller-Hermelink, B Pfistner, V Diehl, and A Engert

Poorer outcome of elderly patients treated with extended-field radiotherapy compared with involved-field radiotherapy after chemotherapy for Hodgkin's lymphoma: an analysis from the German Hodgkin Study Group
Annals of Oncology Advance Access published on October 27, 2006
Ann Oncol 18: 357-363; doi:10.1093/annonc/mdl379
[Abstract] [Full Text] [PDF] [Request Permissions]

E Nitta, K Izutsu, T Sato, Y Ota, K Takeuchi, A Kamijo, K Takahashi, K Oshima, Y Kanda, S Chiba, T Motokura, and M Kurokawa

A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma: a single-institution study
Annals of Oncology Advance Access published on November 1, 2006
Ann Oncol 18: 364-369; doi:10.1093/annonc/mdl393
[Abstract] [Full Text] [PDF] [Request Permissions]

F Morschhauser, S Depil, E Jourdan, M Wetterwald, R Bouabdallah, G Marit, P Solal-Céligny, C Sebban, B Coiffier, N Chouaki, F Bauters, and C Dumontet

Phase II study of gemcitabine–dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphoma
Annals of Oncology Advance Access published on October 30, 2006
Ann Oncol 18: 370-375; doi:10.1093/annonc/mdl395
[Abstract] [Full Text] [PDF] [Request Permissions]

E. Boleti and GM Mead

ABVD for Hodgkin's lymphoma: full-dose chemotherapy without dose reductions or growth factors
Annals of Oncology Advance Access published on October 27, 2006
Ann Oncol 18: 376-380; doi:10.1093/annonc/mdl397
[Abstract] [Full Text] [PDF] [Request Permissions]

oncology practice:

WS Kendal

Suicide and cancer: a gender-comparative study
Annals of Oncology Advance Access published on October 19, 2006
Ann Oncol 18: 381-387; doi:10.1093/annonc/mdl385
[Abstract] [Full Text] [PDF] [Request Permissions]

epidemiology:

C Galeone, E Negri, C Pelucchi, C La Vecchia, C Bosetti, and J Hu

Dietary intake of fruit and vegetable and lung cancer risk: a case–control study in Harbin, northeast China
Annals of Oncology Advance Access published on October 23, 2006
Ann Oncol 18: 388-392; doi:10.1093/annonc/mdl387
[Abstract] [Full Text] [PDF] [Request Permissions]

letters to the editor:

B Souberbielle, R Williams, and E McCloskey

The cost-effectiveness of bisphosphonates in metastatic breast cancer: letter to the editor in response to Botteman et al. 2006
Annals of Oncology Advance Access published on October 16, 2006
Ann Oncol 18: 393; doi:10.1093/annonc/mdl351
[Extract] [Full Text] [PDF] [Request Permissions]

A Cardillo, C De Cicco, G Paganelli, R Ghisini, G Peruzzotti, A Balduzzi, A Goldhirsch, N Rotmensz, P Veronesi, A Luini, M Intra, and M Colleoni

Role of fluorodeoxyglucose positron emission tomography in the staging of patients with breast cancer candidated to surgery
Annals of Oncology Advance Access published on October 16, 2006
Ann Oncol 18: 394-395; doi:10.1093/annonc/mdl354
[Extract] [Full Text] [PDF] [Request Permissions]

L De Lima

International Association for Hospice and Palliative Care list of essential medicines for palliative care
Annals of Oncology Advance Access published on October 27, 2006
Ann Oncol 18: 395-399; doi:10.1093/annonc/mdl373
[Extract] [Full Text] [PDF] [Request Permissions]

M Trujillo and M Morales

Rasburicase-induced fatal respiratory arrest?
Annals of Oncology Advance Access published on October 25, 2006
Ann Oncol 18: 399-400; doi:10.1093/annonc/mdl380
[Extract] [Full Text] [PDF] [Request Permissions]

P Arnaud, M-C Escande, M Lecuit, P Validire, C Levy, C Plancher, A Vincent-Salomon, N Brousse, P de Cremoux, O Hermine, and D Decaudin

Hepatitis C virus infection and MALT-type ocular adnexal lymphoma
Annals of Oncology Advance Access published on October 25, 2006
Ann Oncol 18: 400-401; doi:10.1093/annonc/mdl369
[Extract] [Full Text] [PDF] [Request Permissions]

AJM Ferreri, R Dolcetti, P Musto, GP Dognini, C Doglioni, and M Ponzoni

Reply to the article ‘Hepatitis C virus (HCV) infection and MALT-type ocular adnexal lymphoma (OAL)’ by P. Arnaud, M.-C. Escande, M. Lecuit et al. (Ann Oncol doi:10.1093/annonc/mdl369)
Annals of Oncology Advance Access published on January 5, 2007
Ann Oncol 18: 401-403; doi:10.1093/annonc/mdl423
[Extract] [Full Text] [PDF] [Request Permissions]

A Ottaiano, G Facchini, G Nasti, A Budillon, and M Caraglia

Phase II studies of anticancer chemotherapy: indirect evidence of poor quality
Annals of Oncology Advance Access published on October 27, 2006
Ann Oncol 18: 403; doi:10.1093/annonc/mdl402
[Extract] [Full Text] [PDF] [Request Permissions]

M Mandalà, C Moro, G Michetti, G Ferretti, and R Labianca

What is the real benefit of adjuvant chemotherapy in the Adjuvant Navelbine International Trialist Association trial?
Annals of Oncology Advance Access published on November 9, 2006
Ann Oncol 18: 404; doi:10.1093/annonc/mdl412
[Extract] [Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.